Xeris Biopharma Holdings
XERS
XERS
92 hedge funds and large institutions have $80.4M invested in Xeris Biopharma Holdings in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
3.58% less ownership
Funds ownership: 39.61% → 36.03% (-3.6%)
5% less funds holding
Funds holding: 97 → 92 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
92
Holding in Top 10
2
Calls
$659K
Puts
$61K
Top Buyers
| 1 | +$1.1M | |
| 2 | +$695K | |
| 3 | +$515K | |
| 4 |
DAM
Deltec Asset Management
New York
|
+$413K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$396K |
Top Sellers
| 1 | -$4.32M | |
| 2 | -$4.16M | |
| 3 | -$923K | |
| 4 |
BlackRock
New York
|
-$266K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$163K |